An overview of the OSA, covering its scope, key obligations and what organisations need to navigate the evolving regulatory landscape.
Read more about The Safety Net
Evolving consumer, advertising and competition requirements, and how organisations can prepare for increased enforcement and compliance demands.
Read more about The UK’s consumer law regime (DMCC)
We advise companies in the women's health sector on the commercial, legal and regulatory challenges of bringing new therapies and solutions to market, helping to address the gender health gap.
Read more about Women's health and innovation
What do the latest EU regulatory reforms mean for the future of life sciences innovation?
Bristows’ life sciences regulatory partners Alex Denoon and Xisca Borrás explore key developments in pharmaceutical legislation, medical devices regulation and the proposed Biotech Act, examining what the changes could mean for industry, patient access and Europe’s competitiveness in 2027 and beyond.
Listen below, on Apple Podcasts or Spotify.
/Passle/5f3d6e345354880e28b1fb63/MediaLibrary/Images/2025-09-29-13-48-10-128-68da8e1af6347a2c4b96de4e.png)
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-10-22-14-14-40-225-6ada1a50ce5decc884c006bd.jpg)
/Passle/5f3d6e345354880e28b1fb63/MediaLibrary/Images/2024-08-01-13-11-10-549-66ab896ee543bf94f9636c73.png)
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-10-19-16-18-46-089-6ad642e60d35d5e97b57690e.jpg)